癌症疫苗研究进展

Research progress on the cancer vaccine

导出

摘要随着免疫学机制的深入研究和生物技术的迅速发展,预防、治疗癌症成为疫苗学研究领域新的发展方向。本文综述了近年来癌症疫苗的研究进展情况。 As the immunological and biological technology developing quickly,preventive and therapeutic cancer vaccine have become one of the focus in vaccinology.The author overviewed the research progress on the cancer vaccine in recent years.

作者李娟李长贵

机构地区中国药品生物制品检定所

出处《药物分析杂志》 CAS CSCD 北大核心 2010年第10期1972-1975,共4页 Chinese Journal of Pharmaceutical Analysis

关键词癌症疫苗 cancer vaccine

分类号 R917 [医药卫生—药物分析学]

引文网络
相关文献

参考文献21

1FUTURE Ⅱ Study Group, Quadrivalent vaccine against Human Papillomavirus to prevent high - grade cervical lessions. N Engl J Med ,2007,356 ( 19 ) : 1915.
2Olsson SE, Villa LL, Costa RLR, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus - like particle (VLP) vaccine. Vaccine,2007 (25) :4931.
3Harris JE,Ryan L, Hoover Jr HC, et al. Adjuvant active specific immunotherapy for stage Ⅱ and Ⅲ colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Orwol,2000,18 ( 1 ) : 148.
4Berd D, Maguire Jr HC, Mastrangelo M J, et al. Treatment of human melanoma with a hapten - modified autologous vaccine. Ann NY Acad Sci,1993,690(8) :7.
5Remann R, Goldschmidt AJ, Richter A. Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine : a - year - follow - up analysis. Anticancer Res ,2003 ,23 ( 2 A ) : 969.
6Mitchell MS, Kan - Mitchell J, Kempf RA, et al. Active specific immunotherapy for melanoma:phase Ⅰ trial of allogeneic lysates and a novel adjuvant. Cancer Res, 1988,48 (20) :5883.
7Michael A, Ball G, Quatan N, et al. Delayed disease progression after allogeneic cell vaccine in hormone - resistant prostate cancer and correlation with immunologic variables. Clin Cancer Res, 2005,11 ( 12 ) :4469.
8Morton DL, Hsueh EC, Essner R, et al, Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after resection of melanoma metastatic to regional lymphnodes. Ann Surg,2002,236( 4 ) :438.
9Sondak VK, Sabel MS, Mul' e JJ. Allogeneic and qutologous melanoma vaccine:where have we been and where are we going Clin Cancer Res,2006,12( 7 Pt2) :2337s.
10Renard V, Sonderbye L, Ebbehoj K,et al. HER - 2 DNA and protein vaccine containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER -2 transgenic mice. J Immunol,2003,171 ( 3 ) : 1588.

1全球首批癌症疫苗即将上市[J].中国医院用药评价与分析,2003,3(6):360-360.
2丽娜.癌症疫苗前景美好[J].抗癌,2002(3):36-36.
3首批癌症疫苗即将上市[J].世界科学技术-中医药现代化,2004,6(1):58-58.
4首批癌症疫苗即将上市[J].抗癌,2004(1):10-10.
5Biovest公司癌症疫苗在欧洲提交上市申请[J].中国新药杂志,2012,21(13):1442-1442.
6李莹,郭萌,宋文哲.多表位肿瘤疫苗的研究进展[J].中国新药与临床杂志,2012,31(10):588-593. 被引量：1
7FDA修订癌症疫苗指南[J].国外药讯,2009(11):2-3.
8FDA批准首个癌症疫苗[J].世界临床药物,2006,27(8):451-451.
9熊思东,徐薇.DNA疫苗的研究进展[J].中国处方药,2003,2(2):22-26. 被引量：7
10黄胜炎.妇科用药新制剂[J].上海医药,2008,29(8):358-359. 被引量：1

药物分析杂志

2010年第10期

浏览历史

内容加载中请稍等...

癌症疫苗研究进展

参考文献21

相关作者

相关机构

相关主题

浏览历史